News | Breast Density | November 07, 2023

Whiterabbit’s WRDensity is the first FDA-cleared AI-driven breast density product on ACR’s platform

Whiterabbit’s WRDensity is the first FDA-cleared AI-driven breast density product on ACR’s platform

November 7, 2023 — Whiterabbit.ai, an AI-technology company dedicated to making late-stage diseases a rarity, announced its collaboration with the American College of Radiology (ACR) Data Science Institute (DSI) to make its AI-driven breast density software, WRDensity, available on ACR’s AI-LAB platform. WRDensity is the first FDA-cleared, commercial algorithm on the ACR Connect platform alongside 12 investigational models from other parties. 

“Whiterabbit believes that transparency is fundamental to the effective and equitable adoption of artificial intelligence in healthcare,” said Alex Sardiña, M.D., CEO of Whiterabbit. “Collaborating with an organization that has the caliber and integrity of the American College of Radiology advances our goal to significantly expand the reach and adoption of AI applications such as WRDensity for the betterment of patients.” 

Whiterabbit’s WRDensity is an FDA-cleared AI-driven software that helps radiologists more accurately and more consistently assess breast density.1 Consistent assessment of breast density is vital to effective patient management in support of individualized supplemental screening recommendations to a patient.2 

“ACR’s AI-LAB will use WRDensity in its objective to simplify the evaluation and adoption of AI for uses such as breast density assessment. In turn, this could empower radiologists to develop algorithms at their own institutions to meet their unique clinical needs,” said Laura Coombs, vice president of data science and informatics for the ACR DSI. “ACR DSI facilitates the development, validation and implementation of artificial intelligence applications to expand radiologists’ diagnostic and clinical capabilities to improve medical care.” 

For more information: https://whiterabbit.ai/ 

References: 

1 Matthews TP, Singh S, Mombourquette B, Su J, Shah MP, Pedemonte S, Long A, Maffit D, Gurney J, Hoil RM, Ghare N, Smith D, Moore SM, Marks SC, Wahl RL. A Multisite Study of a Breast Density Deep Learning Model for Full-Field Digital Mammography and Synthetic Mammography. Radiol Artif Intell. 2020 Nov 4;3(1):e200015. doi: 10.1148/ryai.2020200015. PMID: 33937850; PMCID: PMC8082294.
2 Whiterabbit.ai. Longitudinal study of AI in breast density to be presented at RSNA. May 11, 2023. Accessed: June 28, 2023. https://www.whiterabbit.ai/ 

Find more RSNA23 conference coverage here


Related Content

News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | Enterprise Imaging

Mar. 9, 2026 — GE HealthCare recently announced that View, the viewer within the Genesis Radiology Workspace, has ...

Time March 12, 2026
arrow
News | Stroke

March 11, 2026 — Brainomix, a provider of AI-powered imaging tools for stroke and lung fibrosis, has announced the ...

Time March 11, 2026
arrow
News | HIMSS

March 9, 2026 — Fujifilm Healthcare Americas Corp. is showcasing how its latest AI-powered enterprise imaging solutions ...

Time March 10, 2026
arrow
News | Computed Tomography (CT)

March 5, 2026 — At ECR 2026, Royal Philips introduced Rembra, its next-generation radiology CT system designed for the ...

Time March 09, 2026
arrow
News | HIMSS

March 5, 2026 — At the Health Information and Management Systems Society (HIMSS) Conference & Exhibition 2026 in Las ...

Time March 06, 2026
arrow
News | Women's Health

March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the ...

Time March 06, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

March 4, 2026 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Bayer for the expanded ...

Time March 04, 2026
arrow
News | Ultrasound Women's Health

March 2, 2026 — Ultrasound AI, a provider of artificial intelligence applications for medical imaging, has received FDA ...

Time March 03, 2026
arrow
Subscribe Now